Banque Pictet & Cie Sa Dynavax Technologies Corp Transaction History

Banque Pictet & Cie Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$9.44 - $11.88 $323,489 - $407,103	-34,268 Reduced 31.19%	75,585 $741,000
Q4 2022 Feb 06, 2023	SELL	$10.27 - $13.29 $355,968 - $460,644	-34,661 Reduced 23.98%	109,853 $0
Q3 2022 Nov 10, 2022	BUY	$9.93 - $17.44 $166,655 - $292,695	16,783 Added 13.14%	144,514 $1.51 Billion
Q2 2022 Aug 08, 2022	BUY	$7.45 - $12.83 $198,833 - $342,419	26,689 Added 26.41%	127,731 $1.61 Million
Q1 2022 May 04, 2022	BUY	$9.75 - $14.44 $985,159 - $1.46 Million	101,042 New	101,042 $1.1 Million

257

132M

371K

99.2K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.44B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.